Sanaria's malaria vaccine is one step closer to challenging GlaxoSmithKline's Mosquirix, thanks to data from a recent clinical trial.
Robert F. Kennedy Jr. has talked up the already-debunked links between vaccines and autism for more than a decade. Now, President-elect Donald Trump has asked…
Learn why pharma companies must invest in digital technologies and how those that do can grow market share and revenue.
Bavarian Nordic is inclined to remain an independent vaccine company, execs told FiercePharma.
Phase 2b data on Genocea's genital herpes vaccine is boosting confidence in the potential first-in-class shot.
The Army’s decision to transfer a Zika vaccine license to Sanofi has prompted some protest.
Add PaxVax to the list of companies vying to put the first Chikungunya vaccine on the market.
Sanofi's promotional efforts for Dengvaxia have taken a hit in the Philippines.
Bristol-Myers and Bavarian Nordic kicked off testing of the Big Pharma's checkpoint inhibitor Opdivo alongside the biotech's cancer vaccine CV301 in…
Leading players in vaccines need to create more capacity to tackle future outbreak threats, according to Glaxo CEO Andrew Witty.
Pfizer has won a label expansion in Europe for its MenACWY conjugate vaccine Nimenrix.